Ticker Details
Crinetics Pharmaceuticals, Inc.
IPO Date:	July 16, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.15B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.69 | 2.66%
Avg Daily Range (30 D):	$0.72 | 1.92%
Avg Daily Range (90 D):	$1.02 | 2.22%

Institutional Daily Volume
Avg Daily Volume:	.39M
Avg Daily Volume (30 D):	.99M
Avg Daily Volume (90 D):	.93M

Trade Size
Avg Trade Size (Sh.):	62
Avg Trade Size (Sh.) (30 D):	52
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	2,872
Avg Institutional Trade:	$2.86M
Avg Institutional Trade (30 D):	$3.38M
Avg Institutional Trade (90 D):	$4.14M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.53M
Avg Closing Trade (30 D):	$6.1M
Avg Closing Trade (90 D):	$8.9M
Avg Closing Volume:	125.52K

News

Jan 26, 2026 @ 10:00 PM Crinetics Pharmaceuticals to Report Fourth Quarter... Source: Na

Jan 4, 2026 @ 9:00 PM Crinetics Pharmaceuticals to Provide PALSONIFY Bus... Source: Na

Dec 3, 2025 @ 1:00 PM Crinetics Announces First Patient Dosed in Phase 1... Source: Crinetics Pharmaceuticals

Nov 7, 2025 @ 9:16 PM Why Crinetics Pharmaceuticals Stock Was Sliding on... Source: Eric Volkman

Oct 10, 2025 @ 8:41 PM Crinetics Pharmaceuticals Announces October 2025 I... Source: Crinetics Pharmaceuticals

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-4.95	$-1.29	$-4.95
Diluted EPS	$-4.95	$-1.29	$-4.95
Revenue	$7.7M	$6.16M	$7.7M
Gross Profit	$6.62M		$6.62M
Net Income / Loss	$-465.32M	$-122.82M	$-465.32M
Operating Income / Loss	$-516.77M	$-133.67M	$-516.77M
Cost of Revenue	$1.08M		$1.08M
Net Cash Flow	$-163.4M	$-9.76M	$-163.4M
PE Ratio